<html><body><h1>Risk Factors 22</h1><p> <a href="https://www.sec.gov/Archives/edgar/data/1321655/000132165523000011/pltr-20221231.htm">Source: https://www.sec.gov/Archives/edgar/data/1321655/000132165523000011/pltr-20221231.htm</a></p>| Rating | Score |
|--------|-------|
| Negative | Below Average |

The page extracted from the filing contains several provisions that may discourage certain types of transactions that may involve an actual or threatened acquisition of the company. The company's Amended and Restated Investors' Rights Agreement with its affiliates is a matter of concern as it may lead to substantial dilution for the existing stockholders. Any such issuance could result in substantial dilution to our existing stockholders and cause the trading price of our Class A common stock to decline. Furthermore, if securities or industry analysts do not publish research or publish inaccurate or unfavorable research about the company, the trading price and trading volume of the company's Class A common stock could decline. Lastly, there is a possibility that the company may become a controlled company due to the concentration of voting power among the founders and their affiliates. 

Overall, the information in this page of the filing is negative for potential investors, and the score is below average as these provisions may limit the opportunities for stockholders to receive a premium for their shares of the company's Class A common stock, affect the price that some investors are willing to pay for the stock, and potentially impact the trading volume and the price of the stock.</body></html>